We are monitoring the impact of COVID-19 on APAC Infectious Diseases Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4452
Share on
Share on

Asia Pacific Infectious Diseases Diagnostics Market Research Report - Segmented By Product, By Application, By Technology, By End User & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2019-2024)

Pulished: February, 2020
ID: 4452
Pages: 130

APAC Infectious Diseases Diagnostics Market Size & Growth (2019 – 2024)

As per the research report, the Asia Pacific Infectious Diseases Diagnostics Market Size is anticipated to grow at a 8.98% CAGR from 2019 to 2024 and it is estimated that the Asia Pacific market was valued at USD 2.69 billion in 2019 and is relied upon to achieve USD 4.13 billion by 2024 during the forecast period 2019-2024.

Infectious disease diagnostics involves various method to check for the presence of foreign antigen/organism with the help of numerous diagnostic tools. Infectious disease conditions are highly widespread in under developed regions owing to the lack of awareness for personal hygiene, minimal health care expenditures, and absence of efficient physician services. Rising cases of infectious diseases in developed economies is further expected to boost the market growth. This has lead vitro diagnostic device manufacturers to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis.

Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. Being time consuming, disease diagnostics are on a rise. The infectious disease epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise, creating a robust demand for infectious disease diagnostics. With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to boost the market growth in the next few years. However, diagnostic kits are expensive and manufacturers still have a poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

This research report segmented and sub-segmented into the following categories:

  • By Product: Instruments, Reagents, Services, Software
  • By Application: Hepatitis C, AIDS, Tuberculosis
  • By Technology: PCR, INAAT, DNA Sequencing, Hybridization
  • By End User: Hospital, Laboratories
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Asia Pacific Infectious Diseases Diagnostics Market geographical segmentation by India, China, Japan, Australia and South Korea. Asia-Pacific is projected to register the highest growth rate in the coming years, due to the high pervasiveness of infectious diseases, and huge investment opportunities due to a growth in healthcare expenditure.  Countries belonging to Asia-Pacific region have largest share in infectious disease diagnosis market due to high prevalence and incidence of infectious diseases especially sexually transmitted disease and bacterial infections.

The Top companies leading in the APAC Infectious Diseases Diagnostics Market profiled in the report are Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

1.Introduction                              

                1.1 Market Definition                

                1.2 Study Deliverables              

                1.3 Base Currency, Base Year and Forecast Periods                      

                1.4 General Study Assumptions            

2. Research Methodology                                       

                2.1 Introduction                           

                2.2 Research Phases                  

                                2.2.1 Secondary Research       

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling  

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                     

                2.4 Study Timeline                      

3. Overview                                   

                3.1 Executive Summary            

                3.2 Key Inferences                     

                3.3 Epidemology                          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

                4.1 Market Drivers                      

                4.2 Market Restraints                

                4.3 Key Challenges                     

                4.4 Current Opportunities in the Market                          

5. Market Segmentation                                          

                5.1 Product                    

                                5.1.1 Introduction       

                                5.1.2  Instruments & Analyzers                                                 

                                5.1.3 Consumables     

                                                5.1.3.1 Assays and Reagents                                      

                                5.1.4 Services & Softwares      

                                5.1.5  Y-o-Y Growth Analysis, By Product          

                                5.1.6  Market Attractiveness Analysis, By Product        

                                5.1.7  Market Share Analysis, By Product          

                5.2 Technique               

                                5.2.1 Introduction       

                                5.2.2 Traditional Diagnostic Techniques                                                 

                                                5.2.2.1 Immunodiagnostics                                         

                                                5.2.2.2  Microscopy                                        

                                                5.2.2.3 Biochemical Characterization                                       

                                5.2.3 Molecular Diagnostics    

                                                5.2.3.1 PCR                                         

                                                5.2.3.2 INAAT                                    

                                                5.2.3.2 Hybridization                                      

                                                5.2.3.3 DNA Sequencing & NGS                                                

                                                5.2.3.4 Microarray                                           

                                                5.2.3.5 Others                                   

                                5.2.4 Y-o-Y Growth Analysis, By Technique      

                                5.2.5 Market Attractiveness Analysis, By Technique    

                                5.2.6 Market Share Analysis, By Technique      

                5.3 Application             

                                5.3.1 Introduction       

                                5.3.2 Hepatitis B           

                                5.3.3 Hepatitis C           

                                5.3.4 Human Immunodeficiency Virus (HIV)    

                                5.3.5 Tuberculosis (TB)                                                  

                                5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)        

                                5.3.7 Human papillomavirus (HPV)      

                                5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)        

                                5.3.9 Others  

                                5.3.10 Y-o-Y Growth Analysis, By Application  

                                5.3.11  Market Attractiveness Analysis, By Application                                                   

                                5.3.12  Market Share Analysis, By Application 

                5.4 End User                  

                                5.4.1 Introduction       

                                5.4.2 Hospitals  Laboratories   

                                5.4.3 Physician office Labs       

                                5.4.4  Academics          

                                5.4.5 Others  

                                5.4.6 Y-o-Y Growth Analysis, By End User         

                                5.4.7  Market Attractiveness Analysis, By End User      

                                5.4.8  Market Share Analysis, By End User        

6. Geographical Analysis                                          

                6.1 Introduction                           

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis 

                                6.1.3 Y-o-Y Growth Analysis    

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Technique                                     

                                                6.1.3.4 By Application                                    

                                                6.1.3.5 By End User                                        

                                6.1.4  Market Attractiveness Analysis 

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Technique                                     

                                                6.1.4.4 By Application                                    

                                                6.1.4.5 By End User                                        

                                6.1.5  Market Share Analysis  

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Technique                                     

                                                6.1.5.4 By Application                                    

                                                6.1.5.5 By End User                                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia      

7. Strategic Analysis                                   

                7.1 PESTLE analysis                     

                                7.1.1 Political 

                                7.1.2 Economic                                                 

                                7.1.3 Social     

                                7.1.4 Technological     

                                7.1.5 Legal      

                                7.1.6 Environmental   

                7.2 Porter’s Five analysis                          

                                7.2.1 Bargaining Power of Suppliers    

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants 

                                7.2.4 Threat of Substitute Products and Services          

                                7.2.5 Competitive Rivalry within the Industry 

8. Market Leaders' Analysis                                    

                8.1 Abbott Laboratories           

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments   

                                8.1.5 SWOT analysis   

                                8.1.6 Analyst View      

                8.2 bioMérieux SA                      &

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of by Product, Application, Technology and End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  2. Asia Pacific Instruments Market By Region, From 2019-2024 ( USD Billion )
  3. Asia Pacific Reagents Market By Region, From 2019-2024 ( USD Billion )
  4. Asia Pacific Services Market By Region, From 2019-2024 ( USD Billion )
  5. Asia Pacific Software Market By Region, From 2019-2024 ( USD Billion )
  6. Asia Pacific Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  7. Asia Pacific Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  8. Asia Pacific Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  9. Asia Pacific Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  10. Asia Pacific Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  11. Asia Pacific Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  12. Asia Pacific human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  13. Asia Pacific Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  14. Asia Pacific Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  15. Asia Pacific PCR Market By Region, From 2019-2024 ( USD Billion )
  16. Asia Pacific INAAT Market By Region, From 2019-2024 ( USD Billion )
  17. Asia Pacific DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  18. Asia Pacific Hybridization Market By Region, From 2019-2024 ( USD Billion )
  19. Asia Pacific Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  20. Asia Pacific Laboratories Market By Region, From 2019-2024 ( USD Billion )
  21. Asia Pacific Hospital Market By Region, From 2019-2024 ( USD Billion )
  22. Japan Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  23. Japan Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  24. Japan Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  25. Japan Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  26. China Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  27. China Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  28. China Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  29. China Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  30. India Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  31. India Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  32. India Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  33. India Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  34. Australia Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  35. Australia Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  36. Australia Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  37. Australia Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  38. South Korea Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  39. South Korea Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  40. South Korea Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  41. South Korea Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample